Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

Deborah A. Knight; Shin Foong Ngiow; Ming Li; Tiffany Parmenter; Stephen Mok; Ashley Cass; Nicole M. Haynes; Kathryn Kinross; Hideo Yagita; Richard C. Koya; Thomas G. Graeber; Antoni Ribas; Grant A. McArthur; Mark J. Smyth

doi:10.1172/JCI70645

Article tools

Author information

Find articles by
Knight, D. A. in:
JCI | PubMed | Google Scholar
Find articles by
Smyth, M. J. in:
JCI | PubMed | Google Scholar

Need help?

E-mail the JCI

Published in Volume 123, Issue 7 (July 1, 2013)
J Clin Invest. 2013;123(7):3182–3182. doi:10.1172/JCI70645.
Copyright © 2013, American Society for Clinical Investigation

Erratum

View original article

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

Deborah A. Knight, Shin Foong Ngiow, Ming Li, Tiffany Parmenter, Stephen Mok, Ashley Cass, Nicole M. Haynes, Kathryn Kinross, Hideo Yagita, Richard C. Koya, Thomas G. Graeber, Antoni Ribas, Grant A. McArthur and Mark J. Smyth

Published July 1, 2013

Original citation: J. Clin. Invest. 2013;123(3):1371–1381. doi:10.1172/JCI66236.

Citation for this erratum: J. Clin. Invest. 2013;123(7):3182. doi:10.1172/JCI70645.

During preparation of the manuscript, Figure 9 was labeled incorrectly. The correct figure is below.

Figure 9

The JCI regrets the error.

Published in: Volume 123, Issue 7